Recent News
Asbestos Exposure Documentary Makes Debut At International Film Festival
Last weekend at the San Luis Obispo International Film Festival, a 75- minute documentary about asbestos exposure and mesothelioma made its world debut, highlighting the aggressive and often fatal diseases[…]
Biomarker CD47 as a Successful Diagnostic and Treatment Tool
Survival rates for diffuse mesothelioma are notoriously low with the median survival ranging between 12 to 22 months. A contributing factor to treatment being ineffective is that the disease if[…]
Epithelioid Mesothelioma And Reactive Mesothelial Hyperplasia
The type of mesothelioma can be based upon where the cancer is located in the body, but it can also be based upon cell type – meaning, which cell has[…]
Asbestos Cancer Risk Measured by Fiber Length
Since asbestos was used for decades in thousands of products ranging from attic insulation to woven oven mitts, it is hard to imagine that this versatile material is actually a naturally occurring[…]
Asbestos Regulations – National Cancer Prevention Month
Despite the known dangers of asbestos exposure, asbestos is still legal in the United States. However, it is heavily regulated within different organizations in the government. Different agencies have their[…]
Clinical Trial Investigates Multimodality Treatment for Pleural and Peritoneal Mesothelioma
Researchers at the Memorial Sloan Kettering Cancer Center are collaborating with Pfizer to study the effects of immunotherapy treatment Avelumab when combined with stereotactic body radiation therapy, or SBRT, for[…]
Effective Chemotherapy May Rest Upon Reducing Overactive Enzyme
Chemotherapy for mesothelioma patients has been notoriously difficult and the cancer continues to be overwhelmingly unresponsive to such treatment in many cases. However, researchers and scientists have been continually investigating[…]
February is National Cancer Prevention Month
Cancer is the second most leading cause of death in the United States affecting over 500,000 people. However, is estimated that 1/3 of all cancers could be prevented through daily[…]
The Orphan Drug Act and the National Organization for Rare Disorders Bring Attention and Funding to Rare Diseases
Testing and developing new drugs and treatments for an illness is a costly endeavor, but drug companies thrive in this business by being able to sell medication to the sick[…]
Skip to content